Magenta Therapeutics Inc

NASDAQ:MGTA   9:59:25 AM EDT
10.52
-0.11 (-1.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Magenta Therapeutics Inc Stock, NASDAQ:MGTA

100 Technology Square, 5th Floor, Cambridge, Massachusetts 02139
United States of America
Phone: +1.857.242.0170
Number of Employees: 69

Description

Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. It offers patient preparation, stem cell collection, cell dose, and safe immune regeneration programs. Its platform include autologous and allogeneic transplant, and gene therapy. The company was founded by David Scadden, Derrick Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner in June 17, 2015 and is headquartered in Cambridge, MA.